1. |
Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5):395-409.
|
2. |
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 2011, 6(2):244-285.
|
3. |
Godoy MC, Sabloff B, Naidich DP. Subsolid pulmonary nodules: imaging evaluation and strategic management. Curr Opin Pulm Med, 2012, 18(4):304-312.
|
4. |
Suzuki K, Koike T, Asakawa T, et al. A Prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical 1a lung cancer(Japan Clinical Oncology Group 0201). J Thorac Oncol, 2011, 6(4):751-756.
|
5. |
Tsutani Y, Miyata Y, Nakayama H, et al. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Ann Oncol, 2013, 24(9):2376-2381.
|
6. |
Tsutani Y, Miyata Y, Nakayama H, et al. Segmentectomy for clinical stage ⅠA lung adenocarcinoma showing solid dominance on radiology. Euro J Cardio-Thorac Surg, 2014[Epub ahead of print].
|
7. |
Kadota K, Villena-Vargas J, Yoshizawa A, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage Ⅰ disease. Am J Surg Pathol, 2014, 38(4):448-460.
|
8. |
Russell PA, Wainer Z, Wright GM, et al. Does lung adenocarcinoma subtype predict patient survival?:A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. J Thorac Oncol, 2011, 6(9):1496-1504.
|
9. |
Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma:prognostic subgroups and implications for further revision of staging based on analysis of 514 stage Ⅰ cases. Mod Pathol, 2011, 24(5):653-664.
|
10. |
Takahashi M, Shigematsu Y, Ohta M, et al. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage ⅠA lung adenocarcinoma and can be predicted by radiologic parameters. J Thorac Cardiovasc Surg, 2014, 147(1):54-59.
|
11. |
Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl):e93S-120S.
|
12. |
Wang Memoli JS, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest, 2012, 142(2):385-393.
|
13. |
Lin Y, Liu L, Pu Q. Mini-invasive diagnosis and synchronous treatment of solitary pulmonary nodule. Asian Cardiovasc Thorac Ann, 2013, 21(3):306-312.
|
14. |
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3):615-622.
|
15. |
Tarasevych S, Lauwers P, Vandaele F, et al. Novel treatment options in stage Ⅰ non-small-cell lung cancer. Expert Rev Anticancer Ther, 2014, 14(9):1-14.
|
16. |
Howington JA, Blum MG, Chang AC, et al. Treatment of stage Ⅰ and Ⅱ non-small cell lung cancer:Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl):e278S-313S.
|
17. |
Tsutani Y, Miyata Y, Nakayama H, et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage ⅠA lung adenocarcinoma:Wedge resection or segmentectomy. Chest, 2014, 145(1):66-71.
|
18. |
Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer:initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg, 2006, 81(3):1013-1020.
|
19. |
Maniwa T, Okumura T, Isaka M, et al. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg, 2013, 44(1):e59-64.
|
20. |
Shapiro M, Kadakia S, Lim J, et al. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer. Chest, 2013, 144(5):1615-1621.
|
21. |
Yang C-FJ, D'Amico TA. Open, thoracoscopic and robotic segmentectomy for lung cancer. Ann Cardiothorac Surg, 2014, 3(2):142-152.
|
22. |
Liu CY, Lin CS, Shih CH, et al. Single-port video-assisted thoracoscopic surgery for lung cancer. J Thorac Dis, 2014, 6(1):14-21.
|
23. |
Das-Neves-Pereira JC, Bagan P, Coimbra-Israel AP, et al. Fast-track rehabilitation for lung cancer lobectomy:a five-year experience. Eur J Cardiothorac Surg, 2009, 36(2):383-391.
|
24. |
Boujelbene N, Elloumi F, Kamel ME, et al. Stereotactic body radiation therapy in stage Ⅰ inoperable lung cancer:from palliative to curative options. Swiss Med Wkly, 2013, 143:w13780.
|
25. |
Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage Ⅰ non-small cell lung cancer. J Thorac Cardiovasc Surg, 2010, 140(2):377-386.
|
26. |
Solda F, Lodge M, Ashley S, et al. Stereotactic radiotherapy(SABR)for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol, 2013, 109(1):1-7.
|
27. |
Casal RF, Tam AL, Eapen GA. Radiofrequency ablation of lung tumors. Clin Chest Med, 2010, 31(1):151-163.
|
28. |
Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage Ⅰ non-small cell lung cancer. J Thorac Cardiovasc Surg, 2009, 137(1):160-166.
|
29. |
Bi N, Shedden K, Zheng X, et al. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage Ⅰ Non-Small Cell Lung Cancer:A Systemic Review and Meta-analysis. Pract Radiat Oncol, 2013, 3(2 Suppl 1):S19.
|